Selecting patients for gastrectomy in metastatic esophago-gastric cancer: clinics and pathology are not enough

被引:13
|
作者
Fornaro, Lorenzo [1 ]
Fanotto, Valentina [2 ]
Musettini, Gianna [1 ]
Uccello, Mario [3 ]
Rimassa, Lorenza [4 ]
Vivaldi, Caterina [1 ]
Fontanella, Caterina [2 ]
Leone, Francesco [5 ]
Giampieri, Riccardo [6 ]
Rosati, Gerardo [7 ]
Lencioni, Monica [1 ]
Santini, Daniele [8 ]
Di Donato, Samantha [9 ]
Tomasello, Gianluca [10 ]
Brunetti, Oronzo [11 ]
Pietrantonio, Filippo [12 ]
Bergamo, Francesca [13 ]
Scartozzi, Mario [14 ]
Avallone, Antonio [15 ]
Lutrino, Stefania Eufemia [16 ]
Melisi, Davide [17 ]
Antonuzzo, Lorenzo [18 ]
Pellegrino, Antonio [19 ]
Gerratana, Lorenzo [2 ]
Cordio, Stefano [3 ]
Vasile, Enrico [1 ]
Aprile, Giuseppe [2 ,20 ]
机构
[1] Azienda Osped Univ Pisana, Unit Med Oncol 2, I-56126 Pisa, Italy
[2] Univ & Gen Hosp, Dept Oncol, I-33100 Udine, Italy
[3] Garibaldi Nesima Hosp, Dept Oncol, I-95122 Catania, Italy
[4] Humanitas Clin & Res Ctr, Humanitas Canc Ctr, Med Oncol & Hematol Unit, I-20089 Rozzano, MI, Italy
[5] IRCCS, Inst Canc Res & Treatment, I-10060 Candiolo, TO, Italy
[6] Osped Riuniti, Unit Med Oncol, I-60126 Ancona, Italy
[7] San Carlo Hosp, Unit Med Oncol, I-85100 Potenza, Italy
[8] Campus Biomed Univ, Med Oncol, I-00128 Rome, Italy
[9] Gen Hosp, Dept Med Oncol, I-59100 Prato, Italy
[10] Ist Ospitalieri Cremona, Med Oncol Div, I-26100 Cremona, Italy
[11] Natl Canc Inst IRCCS Giovanni Paolo II, Unit Med Oncol, I-70124 Bari, Italy
[12] Natl Canc Inst IRCCS, Med Oncol, I-20133 Milan, Italy
[13] IOV IRCCS, Med Oncol, I-35128 Padua, Italy
[14] Univ Cagliari, Univ Hosp, Unit Med Oncol, I-09124 Cagliari, Italy
[15] IRCCS Fdn G Pascale, Natl Canc Inst, Gastrointestinal Oncol, I-80131 Naples, Italy
[16] Perrino Hosp, Unit Med Oncol, I-72100 Brindisi, Italy
[17] Univ Verona, Unit Med Oncol, I-37126 Verona, Italy
[18] Careggi Univ Hosp, Unit Med Oncol, I-50134 Florence, Italy
[19] Vito Fazzi Hosp, Unit Oncol, I-73100 Lecce, Italy
[20] ULSS 8 Berica East Dist, San Bortolo Gen Hosp, Dept Oncol, I-36100 Vicenza, Italy
关键词
chemotherapy; metastatic gastric cancer; palliative gastrectomy; GASTRIC-CANCER; PALLIATIVE RESECTION; DOUBLE-BLIND; CHEMOTHERAPY; SURGERY; ADENOCARCINOMA; PHASE-3; GUIDELINES;
D O I
10.2217/fon-2017-0246
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To evaluate the impact on overall survival (OS) of gastrectomy in asymptomatic metastaticesophago-gastriccancer.Patients&methods: Five hundred and thirteen patients were included. The role of surgery and other clinico-pathological factors was evaluated by univariate and Cox regression analyses. OS was the primary end point. Results: Multivariate analysis confirmed that gastrectomy was a predictor of longer OS (p < 0.001), as well as preserved performance status and benefit from first-line chemotherapy. None of the investigated clinico-pathological variables identified preferable candidates for surgery (all p > 0.05). Conclusion: Palliative gastrectomy might play a role in asymptomatic metastatic esophago-gastric cancer patients with good performance status who received benefit from first-line chemotherapy. Future prospective trials integrating tumor biology among inclusion criteria may help defining the optimal candidates.
引用
收藏
页码:2265 / 2275
页数:11
相关论文
共 50 条
  • [11] The effectivity of targeted therapy and immunotherapy in patients with advanced metastatic and non-metastatic cancer of the esophagus and esophago-gastric junction
    M. J. Valkema
    B. Mostert
    S. M. Lagarde
    B. P. L. Wijnhoven
    J. J. B. van Lanschot
    Updates in Surgery, 2023, 75 : 313 - 323
  • [12] The surgical management of esophago-gastric junctional cancer
    Kauppila, Joonas H.
    Lagergren, Jesper
    SURGICAL ONCOLOGY-OXFORD, 2016, 25 (04): : 394 - 400
  • [13] Diagnosis and treatment of gastric cancer and adenocarcinoma of the esophago-gastric junction
    Stocker, G.
    Blaeker, H.
    Denecke, T.
    Gockel, I.
    Hoffmeister, A.
    Kuhnt, Th.
    Hambsch, P.
    Lordick, F.
    ONKOLOGE, 2021, 27 (10): : 1033 - 1044
  • [14] Diagnosis and treatment of gastric cancer and adenocarcinoma of the esophago-gastric junction
    Stocker, G.
    Blaeker, H.
    Denecke, T.
    Gockel, I
    Hoffmeister, A.
    Kuhnt, Th
    Hambsch, P.
    Lordick, F.
    GASTROENTEROLOGE, 2022, 17 (02): : 120 - 131
  • [15] Perspectives on the Management of Oligometastatic Disease in Esophago-Gastric Cancer
    Goetze, Thorsten Oliver
    Al-Batran, Salah-Eddin
    CANCERS, 2022, 14 (21)
  • [16] Esophago-Gastric Cancer after One Anastomosis Gastric Bypass (OAGB)
    Runkel, Mira
    Runkel, Norbert
    CHIRURGIA, 2019, 114 (06) : 686 - 692
  • [17] Personalizing chemotherapy to improve esophago-gastric cancer outcomes
    Paterson, Anna
    Gilmer, Tona
    Wooster, Richard
    Fitzgerald, Rebecca
    CANCER RESEARCH, 2009, 69
  • [18] Elevated MDSCs in Pancreatic and Esophago-gastric Cancer Patients Correlates with Poor Prognosis
    Annels, Nicola E.
    Gabitass, Rachel F.
    Pandha, Hardev
    Middleton, Gary W.
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (08) : 897 - 897
  • [19] Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
    Liang, Diana H.
    Kim, Min P.
    Chan, Edward Y.
    Gaur, Puja
    JOURNAL OF GASTROINTESTINAL SURGERY, 2017, 21 (01) : 199 - 201
  • [20] Cervical Esophago-Gastric Tubes for Patients with Malignant Ascites
    Diana H. Liang
    Min P. Kim
    Edward Y. Chan
    Puja Gaur
    Journal of Gastrointestinal Surgery, 2017, 21 : 199 - 201